RPS6KB1 and colorectal carcinoma: One possible common downstream target is S6K as activity of this kinase is reduced after knockdown of STK33 in AML cells (Scholl et al., 2009) and in different cell types, including CRC cells HT-29, after knockdown or pharmacological inhibition of GSK3β (Shin et al., 2011).